• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

轻度帕金森氏征:临床、影像学及病理学关联的系统评价

Mild Parkinsonian Signs: A Systematic Review of Clinical, Imaging, and Pathological Associations.

作者信息

Buchanan Sarah M, Richards Marcus, Schott Jonathan M, Schrag Anette

机构信息

Dementia Research Centre, University College London Institute of Neurology, University College London, London, United Kingdom.

Otago Medical School, University of Otago, Dunedin, New Zealand.

出版信息

Mov Disord. 2021 Nov;36(11):2481-2493. doi: 10.1002/mds.28777. Epub 2021 Sep 25.

DOI:10.1002/mds.28777
PMID:34562045
Abstract

Mild parkinsonian signs (MPS) have been widely studied during the past 3 decades and proposed as a risk marker for neurodegenerative disease. This systematic review explores the epidemiology, clinical and prognostic associations, radiological features, and pathological findings associated with MPS in older adults free from neurodegenerative disease. We find that MPS as currently defined are strongly associated with increasing age and increased risk of development of Parkinson's disease (PD), all-cause dementia, disability, and death. Positive associations with later PD are found mainly in younger populations and those with other features of prodromal PD. There are currently no consistent radiological findings for MPS, and pathological studies have shown that MPS, at least in the oldest old, are often underpinned by mixed neuropathologies, including those associated with Alzheimer's disease, cerebrovascular disease, nigral neuronal loss, and Lewy bodies. Different subcategories of MPS appear to convey varying risk and specificity for PD and other outcomes. MPS overall are not specific for parkinsonian disorders and, although associated with increased risk of PD, can reflect multiple pathologies, particularly in older individuals. "Mild motor signs" appears a more appropriate term to avoid prognostic and pathological implications, and larger future studies to prospectively examine outcomes and associations of specific MPS subcategories are required. © 2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

摘要

在过去30年里,轻度帕金森体征(MPS)得到了广泛研究,并被提议作为神经退行性疾病的风险标志物。本系统评价探讨了无神经退行性疾病的老年人中与MPS相关的流行病学、临床和预后关联、放射学特征及病理发现。我们发现,目前所定义的MPS与年龄增长以及帕金森病(PD)、全因性痴呆、残疾和死亡风险增加密切相关。与晚期PD的正相关主要见于较年轻人群以及具有前驱PD其他特征的人群。目前MPS尚无一致的放射学表现,病理研究表明,MPS至少在高龄老人中常由多种神经病理学改变所支撑,包括与阿尔茨海默病、脑血管疾病、黑质神经元丢失和路易小体相关的改变。MPS的不同亚类似乎对PD和其他结局具有不同的风险和特异性。总体而言,MPS并非帕金森病性障碍所特有,尽管与PD风险增加相关,但可反映多种病理改变,尤其是在老年人中。“轻度运动体征”似乎是一个更合适的术语,以避免预后和病理方面的影响,未来需要开展更大规模的前瞻性研究,以检验特定MPS亚类的结局和关联。© 2021作者。《运动障碍》由Wiley Periodicals LLC代表国际帕金森和运动障碍协会出版。

相似文献

1
Mild Parkinsonian Signs: A Systematic Review of Clinical, Imaging, and Pathological Associations.轻度帕金森氏征:临床、影像学及病理学关联的系统评价
Mov Disord. 2021 Nov;36(11):2481-2493. doi: 10.1002/mds.28777. Epub 2021 Sep 25.
2
Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment.尼麦角林治疗痴呆及其他与年龄相关的认知障碍形式的疗效。
Cochrane Database Syst Rev. 2001;2001(4):CD003159. doi: 10.1002/14651858.CD003159.
3
Safety and tolerability of intravenous liposomal GM1 in patients with Parkinson disease: A single-center open-label clinical phase I trial (NEON trial).静脉注射脂质体GM1治疗帕金森病患者的安全性和耐受性:一项单中心开放标签的I期临床试验(NEON试验)。
PLoS Med. 2025 May 13;22(5):e1004472. doi: 10.1371/journal.pmed.1004472. eCollection 2025 May.
4
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
5
Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia.在痴呆症患者中,停用或继续使用胆碱酯酶抑制剂、美金刚或两者。
Cochrane Database Syst Rev. 2021 Feb 3;2(2):CD009081. doi: 10.1002/14651858.CD009081.pub2.
6
Reminiscence therapy for dementia.痴呆症的回忆疗法
Cochrane Database Syst Rev. 2018 Mar 1;3(3):CD001120. doi: 10.1002/14651858.CD001120.pub3.
7
One-year practice effects predict long-term cognitive outcomes in Parkinson's disease.一年的练习效果可预测帕金森病的长期认知结果。
J Parkinsons Dis. 2025 Apr 29:1877718X251339585. doi: 10.1177/1877718X251339585.
8
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
9
Neuroimaging in Glucocerebrosidase-Associated Parkinsonism: A Systematic Review.神经影像学在葡萄糖脑苷脂酶相关性帕金森病中的应用:系统综述。
Mov Disord. 2022 Jul;37(7):1375-1393. doi: 10.1002/mds.29047. Epub 2022 May 6.
10
Interventions for preventing falls in Parkinson's disease.预防帕金森病跌倒的干预措施。
Cochrane Database Syst Rev. 2022 Jun 6;6(6):CD011574. doi: 10.1002/14651858.CD011574.pub2.

引用本文的文献

1
Motor signs in late life depression relate to altered subcortical synaptic density and gray matter volume: an C-UCB-J PET-MR study.老年抑郁症中的运动体征与皮质下突触密度和灰质体积改变有关:一项C-UCB-J正电子发射断层扫描-磁共振成像研究
Neuropsychopharmacology. 2025 Sep 11. doi: 10.1038/s41386-025-02229-6.
2
Neural basis of motor symptoms in Alzheimer's disease: role of regional tau burden and cognition.阿尔茨海默病运动症状的神经基础:区域tau蛋白负荷与认知的作用
Alzheimers Dement. 2025 Aug;21(8):e70598. doi: 10.1002/alz.70598.
3
Machine learning models based on routine blood and biochemical test data for diagnosis of neurological diseases.
基于常规血液和生化检测数据的机器学习模型用于神经疾病诊断。
Sci Rep. 2025 Jul 30;15(1):27857. doi: 10.1038/s41598-025-09439-4.
4
Mesocorticolimbic dopaminergic innervation modulates Levodopa-related improvements in gait in older slow walking Adults: A [C]PE2I PET study.中脑皮质边缘多巴胺能神经支配调节老年慢步行成年人左旋多巴相关的步态改善:一项[C]PE2I正电子发射断层扫描研究。
Clin Park Relat Disord. 2025 May 31;12:100353. doi: 10.1016/j.prdoa.2025.100353. eCollection 2025.
5
Mild motor signs and depression: more than just medication side effects?轻度运动体征与抑郁:仅仅是药物副作用吗?
Eur Arch Psychiatry Clin Neurosci. 2025 Apr 25. doi: 10.1007/s00406-025-02015-x.
6
Aging, frailty, and their effects on motor performance: evidence from kinematic analysis.衰老、虚弱及其对运动表现的影响:来自运动学分析的证据。
Neurol Sci. 2025 Mar 18. doi: 10.1007/s10072-025-08092-z.
7
Parkinsonism in Alzheimer's disease without Lewy bodies in association with nigral neuron loss: A data-driven clinicopathologic study.无路易小体的阿尔茨海默病合并帕金森综合征与黑质神经元丢失:一项数据驱动的临床病理研究。
Alzheimers Dement. 2025 Mar;21(3):e14628. doi: 10.1002/alz.14628.
8
Mild behavioral impairment in idiopathic REM sleep behavior disorder and Lewy body disease continuum.特发性快速眼动睡眠行为障碍与路易体病连续体中的轻度行为损害。
J Neural Transm (Vienna). 2025 May;132(5):637-644. doi: 10.1007/s00702-024-02877-w. Epub 2025 Jan 9.
9
The centenarian blueprint: lessons in defying Parkinson's disease.百岁老人的秘诀:对抗帕金森病的经验教训。
J Neural Transm (Vienna). 2025 Mar;132(3):331-339. doi: 10.1007/s00702-024-02875-y. Epub 2024 Dec 27.
10
Subtle bradykinesia features are easier to identify and more prevalent than questionable dystonia in essential tremor.在特发性震颤中,轻微的运动迟缓特征比特发性肌张力障碍更容易识别且更常见。
J Neural Transm (Vienna). 2025 Mar;132(3):443-454. doi: 10.1007/s00702-024-02861-4. Epub 2024 Nov 21.